1-800 Contacts in talks for buyout

Article

As brick and mortars stores struggle, 1-800 Contacts surges

KKR & Co. Inc is in advanced talks to buy 1-800 Contacts, the largest retailer of contact lenses in the U.S., from investment firm AEA Investors LP, in a deal worth more than $3 billion.

According to Bloomberg News, sources familiar with the acquisition reported KKR beat out rival private equity firms in an auction for the contact lens retailer.1 The decision is not yet public, and talks could still fall through.

1-800 Contacts started in a dorm room in 1995, according to the company. The company was traded on Nasdaq for about a decade before being bought by private-equity firm Fenway Partners in 2007. When the COVID-19 pandemic began, it saw enormous growth and a surge of sales as consumers left brick-and-mortar stores for online alternatives.

The optometric community and the U.S. Food and Drug Administration (FDA) have been at odds with online glasses and contact lens retailers, including 1-800 Contacts, for years because of public health concerns with counterfeit products being sold.

See more: FDA authorizes first COVID-19 point-of-care antibody test

ODs weigh in

Optometry Times® asked optometrists about the acquisition and found that public health topped their list of concerns. Editorial Advisory Board member David I. Geffen, OD, FAAO, warns ODs of the dangers facing eye care and suggests stressing the value of comprehensive eye exams to patients thinking of ordering online.

“The advent of private equity money coming into eye care is going to make the product side of the business more competitive than ever,” Geffen says. “Independent doctors need to provide value for service and make sure their patients realize what they are getting from them instead of just ordering from a bot!”

Editorial Advisory Board member Mile Brujic, OD, FAAO, stresses the importance of patient healthcare needs and not business profitability.

“Healthcare providers make business decisions in their offices based on improving patient care; businesses look for opportunities in health care and at times prioritize profitability ahead of patient care,” Brujic says. “We hope that the acquisition is a responsible one that places patient’s healthcare needs first."

Related: 1-800 Contacts ramps up legislative fights

See more: Brain stimulation can reduce the effects of macular degeneration

Reference

1. Ahmed N, Porter K, Tse C. KKR nears $3 billion-plus deal to buy 1-800 Contacts. Bloomberg. Available at: https://www.bloomberg.com/news/articles/2020-09-22/kkr-said-to-near-3-billion-plus-deal-to-buy-1-800-contacts. Accessed 9/23/20.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Presenters from the Collaborative Care Symposium 2025 give their key takeaways from their presentations.
Erin Tomiyama, OD, PhD, FAAO, offers actionable advice for myopia management and perspective for practitioners ready to refine their approach.
Extended lotilaner 0.25% therapy shows meibomian gland benefits
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Lori Wright, JD, sat down to talk about a presentation at Collaborative Care Symposium about the risk under federal statutes and how to minimize that risk as an optometrist or an ophthalmic practice.
Rachelle Lin, OD, MS, FAAO, on collaborating more effectively on neovascular retinal cases
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
© 2025 MJH Life Sciences

All rights reserved.